Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (751-760 of 6,835) with videos related to

Pageof 684
Sort By:
Nature|May 15, 2024
Experimental obesity drug packs double punch to reduce weightAsher Mullard
Nature Reviews. Drug Discovery|March 29, 2024
FDA approves gene therapy for metachromatic leukodystrophy, the tenth for a genetic disease and the priciest yetAsher Mullard
Nature Reviews. Drug Discovery|July 8, 2025
FDA approves twice-yearly capsid inhibitor for HIV preventionAsher Mullard
Nature Reviews. Drug Discovery|July 9, 2025
Lilly buys Verve and its in vivo gene editors for up to US$1.3 billionAsher Mullard
Entropy (Basel, Switzerland)|February 25, 2023
Pauli's Electron in Ehrenfest and Bohm Theories, a Comparative StudyAsher Yahalom
Nature Reviews. Drug Discovery|April 16, 2025
Back to therapeutic modality basicsAsher Mullard
Nature Reviews. Drug Discovery|October 31, 2024
FDA approves first anti-TFPI antibody for haemophilia A and BAsher Mullard
Nature Reviews. Drug Discovery|October 31, 2024
FDA approves PI3Kα inhibitor that does double duty as a degraderAsher Mullard
Nature Reviews. Drug Discovery|July 30, 2025
In vivo CAR T cells gain traction, with AbbVie's US$2.1 billion acquisition of Capstan TherapeuticsAsher Mullard
Nature Reviews. Drug Discovery|March 14, 2023
Proximity-inducing drugs get closerAsher Mullard
Pageof 684

Showing results (751-760 of 6,835) with videos related to

Sort By:
Pageof 684
Nature|May 15, 2024
Experimental obesity drug packs double punch to reduce weightAsher Mullard
Nature Reviews. Drug Discovery|March 29, 2024
FDA approves gene therapy for metachromatic leukodystrophy, the tenth for a genetic disease and the priciest yetAsher Mullard
Nature Reviews. Drug Discovery|July 8, 2025
FDA approves twice-yearly capsid inhibitor for HIV preventionAsher Mullard
Nature Reviews. Drug Discovery|July 9, 2025
Lilly buys Verve and its in vivo gene editors for up to US$1.3 billionAsher Mullard
Entropy (Basel, Switzerland)|February 25, 2023
Pauli's Electron in Ehrenfest and Bohm Theories, a Comparative StudyAsher Yahalom
Nature Reviews. Drug Discovery|April 16, 2025
Back to therapeutic modality basicsAsher Mullard
Nature Reviews. Drug Discovery|October 31, 2024
FDA approves first anti-TFPI antibody for haemophilia A and BAsher Mullard
Nature Reviews. Drug Discovery|October 31, 2024
FDA approves PI3Kα inhibitor that does double duty as a degraderAsher Mullard
Nature Reviews. Drug Discovery|July 30, 2025
In vivo CAR T cells gain traction, with AbbVie's US$2.1 billion acquisition of Capstan TherapeuticsAsher Mullard
Nature Reviews. Drug Discovery|March 14, 2023
Proximity-inducing drugs get closerAsher Mullard
Pageof 684